LP
RYTM icon

LMR Partners’s Rhythm Pharmaceuticals RYTM Stock Holding History

LMR Partners’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-43,114
Closed -$769K – 1077
2023
Q1 		$769K Buy
43,114
+18,070
+72% +$454K 0.01% 651
2022
Q4 		$729K Buy
25,044
+9,331
+59% +$240K 0.01% 788
2022
Q3 		$385K Hold
15,713
– – 0.01% 925
2022
Q2 		$65K Buy
+15,713
New +$86K ﹤0.01% 1138

Other funds holding RYTM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

LMR Partners's RYTM Position: Q2 2023 in Review

LMR Partners sold out of Rhythm Pharmaceuticals (RYTM) in Q2 2023, closing a stake of 43,114 shares — an estimated $769K sold.

LMR Partners first reported a position in RYTM in Q2 2022 and held it in 4 quarters. The position peaked at $769K in Q1 2023. 116 funds tracked by Wall St. Rank hold RYTM as of Q2 2023.

  • LMR Partners reported no remaining Rhythm Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • LMR Partners sold 43,114 Rhythm Pharmaceuticals shares in Q2 2023, an estimated $769K.
  • LMR Partners first reported a position in Rhythm Pharmaceuticals in Q2 2022 and held it in 4 quarters.
  • LMR Partners's Rhythm Pharmaceuticals position peaked at $769K in Q1 2023.
  • 116 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2023.

Based on LMR Partners's 13F filing for Q2 2023, filed 14 Aug 2023.